All In MedTech

Device Trial Radar · NCT07872670

Virtual Reality Therapy to Improve Arthroplasty Outcomes

Pilot Randomised Controlled Trial of Virtual Reality Immersive Therapy (VRIT) in Addition to Usual Care Compared to Usual Care in Patients Undergoing Joint Arthroplasty - VROOM Trial

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Mar 5, 2026

Primary completion

Dec 1, 2026

Study completion Dec 1, 2026

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Healthy Mind
First posted
Oct 13, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Virtual reality (VR) has recently emerged as a non-medication-based method to manage anxiety. The patient wears a VR headset and is offered an immersive environment with hypnotic components with sound and imagery in a 3D environment. VR creates an immersive 3D environment and diverts attention away from worrying thoughts (anxiety) and pain and has been found useful to manage minor procedural pain and related anxiety. This is a pilot feasibility trial to evaluate the effectiveness of VR in improving patient related outcomes (PROM) after joint replacement surgery.

Conditions

  • Surgical
  • Anxiety
  • Pain Management
  • Joint (Knee or Hip Replacement)

Interventions

  • Virtual Reality HeadsetDevice

    Use of VR Headset for 20 minutes per day, from between 10 and 7 days pre surgery to 30 days post surgery

  • Blood SamplesDiagnostic test

    Blood samples will be collected from 5 participants randomly selected from each arm. Samples will be collected at baseline, day of surgery, 24 hours post surgery, 30 days post surgery and 90 days post surgery

  • QuestionnairesBehavioral

    Baseline and then FU data at 7, 14, 21, 30 and 90 days post-operative will be collected from participants via questionnaires

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients who refuse to participate in the studyTime frame: From 10 days pre surgery to 90 days post surgery
  2. Percentage of participants with complete questionnairesTime frame: From 10 days pre surgery to 90 days post surgery
  3. Participant VR Headset Use Compliance RateTime frame: From 7 days pre surgery to 30 days post surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Treatment Centre - Highland

    Inverness, Highlands, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.